Tardive Dyskinesia clinical trials

Explore recruiting tardive dyskinesia clinical trials.

Recruiting tardive dyskinesia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tardive Dyskinesia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open label, Safety Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia

Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD)

Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia with open-label Part I and randomized, double-blind, placebo-controlled Part II.

Hungary, Czechia, Slovakia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Tardive Dyskinesia trials by city

Tardive Dyskinesia in Toronto Tardive Dyskinesia in Vancouver Tardive Dyskinesia in Montreal Tardive Dyskinesia in Calgary Tardive Dyskinesia in Edmonton Tardive Dyskinesia in Ottawa Tardive Dyskinesia in Winnipeg Tardive Dyskinesia in Quebec City Tardive Dyskinesia in Hamilton Tardive Dyskinesia in Kitchener Tardive Dyskinesia in London Tardive Dyskinesia in Halifax Tardive Dyskinesia in New York Tardive Dyskinesia in Los Angeles Tardive Dyskinesia in Chicago Tardive Dyskinesia in Houston

Tardive Dyskinesia clinical trials

Recruiting tardive dyskinesia studies right now

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Also recruiting in Europe

An Open label, Safety Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia

Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD)

Clinical trial of (+)-α-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia with open-label Part I and randomized, double-blind, placebo-controlled Part II.

Tardive Dyskinesia trials by city

Other conditions